Vertex Pharmaceuticals (VRTX) Prepaid Assets (2009 - 2026)
Vertex Pharmaceuticals (VRTX) recorded quarterly Prepaid Assets of $720.8 million in Q1 2026, down 15.53% quarter-over-quarter from $853.3 million in Q4 2025, and up 12.13% on a YoY basis from $642.8 million in Q1 2025.
Vertex Pharmaceuticals (VRTX) Prepaid Assets (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $720.8 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 12.13% year-over-year to $720.8 million; the TTM figure through Mar 2026 stood at $720.8 million (up 12.13% YoY), while the FY2025 annual figure was $853.3 million, up 1016.88% from the prior year.
- Prepaid Assets was $720.8 million for Q1 2026 at Vertex Pharmaceuticals, down from $853.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $853.3 million in Q4 2025 to a low of $74.4 million in Q4 2022.
- Historically, Prepaid Assets has averaged $506.1 million across 5 years, with a median of $540.2 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets fell 25.68% in 2023, then surged 1016.88% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $74.4 million in 2022, then rose by 13.31% to $84.3 million in 2023, then retreated by 9.37% to $76.4 million in 2024, then soared by 1016.88% to $853.3 million in 2025, then slipped by 15.53% to $720.8 million in 2026.
- The last three Prepaid Assets figures came in at $720.8 million (Q1 2026), $853.3 million (Q4 2025), and $709.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720.80 Mn |
| Dec 31, 2025 | 853.30 Mn |
| Sep 30, 2025 | 709.40 Mn |
| Jun 30, 2025 | 652.30 Mn |
| Mar 31, 2025 | 642.80 Mn |
| Dec 31, 2024 | 76.40 Mn |
| Sep 30, 2024 | 449.20 Mn |
| Jun 30, 2024 | 575.40 Mn |
| Mar 31, 2024 | 511.10 Mn |
| Dec 31, 2023 | 84.30 Mn |
| Sep 30, 2023 | 540.20 Mn |
| Jun 30, 2023 | 476.90 Mn |
| Mar 31, 2023 | 468.70 Mn |
| Dec 31, 2022 | 74.40 Mn |
| Sep 30, 2022 | 726.90 Mn |
| Jun 30, 2022 | 549.50 Mn |
| Mar 31, 2022 | 491.50 Mn |
| Dec 31, 2021 | 59.20 Mn |
| Sep 30, 2021 | 457.83 Mn |
| Jun 30, 2021 | 498.76 Mn |